4893 items matching your search terms.

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

Tebbutt, NC Cummins, MM Sourjina, T Strickland, A Van Hazel, G Ganju, V Gibbs, D Stockler, M Gebski, V Zalcberg, J; on behalf of the Australasian Gastro-Intestinal Trials Group,

Randomised, phase II study of weekly docetaxel, cisplatin and 5-fluorouracil or capecitabine given with or without panitumumab in advanced oesophago-gastric cancer: the AGITG ATTAX 3 trial

Tebbutt, NC Gebski, VJ Hall, M Wong, N Veillard, AS Wilcken, N Price, TJ

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastro-Intestinal Trials Group randomized phase III MAX study

Tebbutt, N.C. Wilson, K. Gebski, V.J. Cummins, M.M. Zannino, D. van Hazel, G.A. Robinson, B. Broad, A. Ganju, V. Ackland, S.P. Forgeson, G. Cunningham, D. Saunders, M.P. Stockler, M.R. Chua, Y.J. Zalcberg, J.R. Simes, R.J. Price, T.J.
JOURNAL OF CLINICAL ONCOLOGY, 2010     DOI:10.1200/jco.2009.27.7723

Cardiovascular and renal safety of fenofibrate in the FIELD study

Ting, RD Davis, T Drury, P Donoghoe, M Rajamani, K Best, J Kesaniemi, A Keech, A on behalf of the FIELD study investigators

Cardiovascular and renal safety of fenofibrate in the FIELD study

Ting, RD Davis, T Drury, P Donoghoe, M Rajamani, K Best, J Kesaniemi, A Keech, A on behalf of the FIELD study investigators,

The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients

Veness, M Foote, M Gebski, V Poulsen, M
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010     DOI:DOI: 10.1016/j.ijrobp.2009.08.011

The Australian HTA review: are we moving towards harmonisation of process?

Wortley, S Lewis, S

Useful estimates of survival for patients starting first line chemotherapy for advanced non-small-cell lung cancer based on a systematic review of recent randomized trials

Alam, M Blinman, P Stockler, MR

Fibrates and microvascular complications in diabetes—insight from the FIELD study

Ansquer, JC Foucher, C Aubonnet, P Le Malicot, K

Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants

Askie, LM Henderson-Smart, DJ Ko, H

Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 trial

Au, HJ Karapetis, CS O'Callaghan, CJ Tu, D Moore, MJ Zalcberg, JR Kennecke, H Shapiro, JD Koski, S Pavlakis, N Charpentier, D Wyld, D Jefford, M Knight, GJ Magoski, NM Brundage, MD Jonker, DJ
JOURNAL OF CLINICAL ONCOLOGY, 2009     DOI:10.1200/jco.2008.19.6048

Screening for prostate cancer: explaining new trial results and their implications to patients

Barratt, AL Stockler, Martin R.

Clinical practice guidelines for the management of adult gliomas: astrocytomas and oligodendrogliomas

Barton, M Hovey, E Reeve, T

Sex differences in mortality following acute coronary syndromes

Berger, JS; Elliott, L; Gallup, D; Roe, M; Granger, CB; Armstrong, PW; Simes, RJ; White, HD; Van de Werf, F; Topol, EJ; Hochman, JS; Newby, LK; Harrington, RA; Califf, RM; Becker, RC; Douglas, PS
JAMA, 2009     DOI:10.1001/jama.2009.1227

Third consensus on medical treatment of metastatic breast cancer

Beslija, S Bonneterre, J Burstein, HJ Cocquyt, V Gnant, M Heinemann, V Jassem, J Kostler, WJ Krainer, M Menard, S Petit, T Petruzelka, L Possinger, K Schmid, P Stadtmauer, E Stockler, M Van Belle, S Vogel, C Wilcken, N Wiltschke, C Zielinski, CC Zwierzina, H for the Central European Cooperative Oncology Group,
ANNALS OF ONCOLOGY, 2009     DOI:10.1093/annonc/mdp261